Healthcare provider profile · identity verified

Alexandra Van Dyck, MD

Internal Medicine · TOWNSHEND, VT · NPI 1144424979

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Furosemide	Furosemide	666	42
Levothyroxine Sodium	Levothyroxine Sodium	646	58
Atorvastatin Calcium	Atorvastatin Calcium	603	54
Metoprolol Succinate	Metoprolol Succinate	464	37
Metoprolol Tartrate	Metoprolol Tartrate	395	22
Lisinopril	Lisinopril	359	32
Sertraline Hcl	Sertraline Hcl	341	23
Eliquis	Apixaban	333	26
Amlodipine Besylate	Amlodipine Besylate	324	39
Escitalopram Oxalate	Escitalopram Oxalate	320	23
Gabapentin	Gabapentin	318	31
Famotidine	Famotidine	308	15
Pantoprazole Sodium	Pantoprazole Sodium	268	27
Duloxetine Hcl	Duloxetine Hcl	250	17
Trazodone Hcl	Trazodone Hcl	235	23
Tamsulosin Hcl	Tamsulosin Hcl	204	14
Metformin Hcl	Metformin Hcl	201	25
Mirtazapine	Mirtazapine	186	suppressed
Potassium Chloride	Potassium Chloride	180	12
Simvastatin	Simvastatin	166	22
Rosuvastatin Calcium	Rosuvastatin Calcium	162	24
Clopidogrel	Clopidogrel Bisulfate	154	suppressed
Levetiracetam	Levetiracetam	147	suppressed
Losartan Potassium	Losartan Potassium	146	23
Risperidone	Risperidone	143	suppressed
Finasteride	Finasteride	142	suppressed
Omeprazole	Omeprazole	142	23
Venlafaxine Hcl Er	Venlafaxine Hcl	125	suppressed
Allopurinol	Allopurinol	120	12
Torsemide	Torsemide	117	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	111	suppressed
Xarelto	Rivaroxaban	108	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	107	suppressed
Topiramate	Topiramate	104	suppressed
Montelukast Sodium	Montelukast Sodium	102	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	100	14
Bupropion Xl	Bupropion Hcl	97	11
Citalopram Hbr	Citalopram Hydrobromide	93	suppressed
Lamotrigine	Lamotrigine	89	suppressed
Hydrochlorothiazide	Hydrochlorothiazide	87	18
Olanzapine	Olanzapine	81	suppressed
Spironolactone	Spironolactone	79	suppressed
Baclofen	Baclofen	78	suppressed
Jardiance	Empagliflozin	76	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	72	suppressed
Donepezil Hcl	Donepezil Hcl	67	suppressed
Oseltamivir Phosphate	Oseltamivir Phosphate	65	65
Bupropion Hcl Sr	Bupropion Hcl	64	suppressed
Divalproex Sodium	Divalproex Sodium	64	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	58	suppressed
Sucralfate	Sucralfate	57	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	55	suppressed
Carvedilol	Carvedilol	54	suppressed
Buspirone Hcl	Buspirone Hcl	53	suppressed
Meloxicam	Meloxicam	53	suppressed
Labetalol Hcl	Labetalol Hcl	52	suppressed
Primidone	Primidone	52	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	50	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	48	suppressed
Alendronate Sodium	Alendronate Sodium	47	13
Glipizide Er	Glipizide	46	suppressed
Lorazepam	Lorazepam	45	19
Acebutolol Hcl	Acebutolol Hcl	43	suppressed
Diltiazem 24hr Er	Diltiazem Hcl	41	suppressed
Diltiazem Hcl	Diltiazem Hcl	41	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	39	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	38	suppressed
Colchicine	Colchicine	37	suppressed
Nifedipine Er	Nifedipine	37	suppressed
Diltiazem 24hr Er (La)	Diltiazem Hcl	35	suppressed
Fluticasone Propionate	Fluticasone Propionate	34	11
Carbidopa-Levodopa	Carbidopa/Levodopa	33	suppressed
Propranolol Hcl	Propranolol Hcl	32	suppressed
Ramelteon	Ramelteon	32	suppressed
Prednisone	Prednisone	31	20
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	29	suppressed
Digoxin	Digoxin	29	suppressed
Irbesartan	Irbesartan	29	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	29	22
Alfuzosin Hcl Er	Alfuzosin Hcl	28	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	28	22
Lurasidone Hcl	Lurasidone Hcl	28	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	27	17
Alprazolam	Alprazolam	27	suppressed
Myrbetriq	Mirabegron	27	suppressed
Aripiprazole	Aripiprazole	26	suppressed
Bupropion Hcl	Bupropion Hcl	26	suppressed
Carbamazepine Er	Carbamazepine	26	suppressed
Cilostazol	Cilostazol	26	suppressed
Combivent Respimat	Ipratropium/Albuterol Sulfate	26	suppressed
Glipizide	Glipizide	26	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	26	suppressed
Memantine Hcl	Memantine Hcl	26	suppressed
Memantine Hcl Er	Memantine Hcl	26	suppressed
Metolazone	Metolazone	26	suppressed
Ropinirole Hcl	Ropinirole Hcl	26	suppressed
Tramadol Hcl	Tramadol Hcl	26	suppressed
Tadalafil	Tadalafil	25	suppressed
Tizanidine Hcl	Tizanidine Hcl	25	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	24	suppressed
Xifaxan	Rifaximin	24	suppressed
Dalfampridine Er	Dalfampridine	23	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	23	suppressed
Vascepa	Icosapent Ethyl	23	suppressed
Warfarin Sodium	Warfarin Sodium	23	suppressed
Azithromycin	Azithromycin	22	18
Clozapine	Clozapine	22	suppressed
Divalproex Sodium Er	Divalproex Sodium	22	suppressed
Methimazole	Methimazole	22	suppressed
Clonazepam	Clonazepam	21	suppressed
Mirabegron Er	Mirabegron	21	suppressed
Trospium Chloride	Trospium Chloride	21	suppressed
Venlafaxine Hcl	Venlafaxine Hcl	21	suppressed
Carbamazepine	Carbamazepine	20	suppressed
Glimepiride	Glimepiride	20	suppressed
Lubiprostone	Lubiprostone	20	suppressed
Metformin Hcl Er	Metformin Hcl	20	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	19	suppressed
Latanoprost	Latanoprost	19	suppressed
Lovastatin	Lovastatin	19	suppressed
Methocarbamol	Methocarbamol	19	suppressed
Oxycodone Hcl	Oxycodone Hcl	19	14
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	17	16
Armour Thyroid	Thyroid,pork	17	suppressed
Folic Acid	Folic Acid	17	suppressed
Pravastatin Sodium	Pravastatin Sodium	17	suppressed
Spiriva Respimat	Tiotropium Bromide	17	suppressed
Ezetimibe	Ezetimibe	16	suppressed
Propranolol Hcl Er	Propranolol Hcl	16	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	15	suppressed
Nystatin	Nystatin	15	13
Albuterol Sulfate	Albuterol Sulfate	14	suppressed
Ozempic	Semaglutide	14	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	14	13
Trospium Chloride Er	Trospium Chloride	14	suppressed
Cefpodoxime Proxetil	Cefpodoxime Proxetil	13	11
Estradiol	Estradiol	13	suppressed
Risperidone Er	Risperidone Microspheres	13	suppressed
Synthroid	Levothyroxine Sodium	13	suppressed
Amoxicillin	Amoxicillin	12	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	12	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	12	suppressed
Novolog Flexpen	Insulin Aspart	12	suppressed
Tresiba Flextouch U-100	Insulin Degludec	12	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	12	suppressed
Verapamil Er	Verapamil Hcl	12	suppressed
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	11	suppressed
Cephalexin	Cephalexin	11	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	11	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	11	suppressed
Ketoconazole	Ketoconazole	11	suppressed
Lidocaine	Lidocaine	11	suppressed
Orencia	Abatacept	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error